Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 13 November 2009, doi:10.1136/bmj.b4739
Cite this as: BMJ 2009;339:b4739
Bob Roehr
1 Washington, DC
| The first 150 words of the full text of this article appear below. |
The current path of HIV prevention and treatment in lower and middle income countries will result in a continued pandemic in 2031, the 50th anniversary of the recognition of the virus.
Costs will have escalated to $35bn (£21bn;
23bn), more than three times current expenditures, and more than a million people will continue to be infected each year.
These are the key findings of the AIDS 2031 Project (www.aids2031.org), a consortium of organisations involved with the pandemic. The project has modelled current and alternative activities, seeking to determine "what can we do to move the epidemic in the most positive direction possible," Robert Hecht, told a news conference in Washington, DC, on 10 November.
"More money alone is not the answer," he said. Spending must become smarter and tailored more to local conditions.
"To get more value from the money that we do spend, we need to concentrate
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?